tiprankstipranks
Sabra Healthcare REIT (MX:SBRA)
:SBRA
Mexico Market
SBRA
Sabra Healthcare REIT
RESEARCH TOOLSreports

Sabra Healthcare REIT (SBRA) Ratios

0 Followers

Sabra Healthcare REIT Ratios

MX:SBRA's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, MX:SBRA's free cash flow was decreased by $ and operating cash flow was $-0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 43.68 0.56 0.88 0.78 0.59
Quick Ratio
 43.68 0.56 0.88 0.78 0.59
Cash Ratio
 27.97 0.21 0.27 0.18 0.15
Solvency Ratio
 0.10 0.13 0.12 0.08 0.04
Operating Cash Flow Ratio
 44.87 1.03 1.38 1.30 0.93
Short-Term Operating Cash Flow Coverage
 343.73 1.60 2.91 3.18 1.60
Net Current Asset Value
$ -2.40B$ -2.48B$ -2.36B$ -2.40B$ -2.49B
Leverage Ratios
Debt-to-Assets Ratio
 0.48 0.46 0.46 0.45 0.44
Debt-to-Equity Ratio
 0.96 0.90 0.89 0.87 0.83
Debt-to-Capital Ratio
 0.49 0.47 0.47 0.47 0.45
Long-Term Debt-to-Capital Ratio
 0.49 0.45 0.46 0.45 0.43
Financial Leverage Ratio
 2.00 1.95 1.93 1.92 1.88
Debt Service Coverage Ratio
 4.01 1.38 1.86 1.49 0.71
Interest Coverage Ratio
 1.15 2.35 2.23 1.96 2.23
Debt to Market Cap
 0.50 0.55 0.60 0.73 0.87
Interest Debt Per Share
 10.84 11.03 10.96 11.07 11.49
Net Debt to EBITDA
 6.73 5.43 5.78 7.71 11.53
Profitability Margins
Gross Profit Margin
72.58%65.00%67.71%69.85%73.97%
EBIT Margin
17.39%34.83%34.55%19.88%4.66%
EBITDA Margin
41.75%58.97%58.67%48.15%34.71%
Operating Profit Margin
11.84%34.06%36.55%34.24%37.59%
Pretax Profit Margin
7.36%20.31%18.16%2.43%-12.22%
Net Profit Margin
7.61%20.09%18.02%2.12%-12.42%
Continuous Operations Profit Margin
7.37%20.08%18.02%2.12%-12.42%
Net Income Per EBT
103.51%98.90%99.21%87.30%101.63%
EBT Per EBIT
62.12%59.63%49.69%7.11%-32.52%
Return on Assets (ROA)
1.19%2.83%2.39%0.26%-1.35%
Return on Equity (ROE)
2.34%5.51%4.62%0.49%-2.54%
Return on Capital Employed (ROCE)
1.85%5.12%5.06%4.30%4.34%
Return on Invested Capital (ROIC)
23.27%4.85%4.92%3.69%4.19%
Return on Tangible Assets
1.21%2.87%2.40%0.26%-1.36%
Earnings Yield
1.25%3.40%3.13%0.42%-2.70%
Efficiency Ratios
Receivables Turnover
 6.61 6.96 5.34 4.84 4.22
Payables Turnover
 3.24 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.16 0.14 0.13 0.12 0.11
Working Capital Turnover Ratio
 3.67 -8.91 -18.21 -6.88 -47.34
Cash Conversion Cycle
 -57.48 52.44 68.38 75.43 86.40
Days of Sales Outstanding
 55.24 52.44 68.38 75.43 86.40
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 112.72 0.00 0.00 0.00 0.00
Operating Cycle
 55.24 52.44 68.38 75.43 86.40
Cash Flow Ratios
Operating Cash Flow Per Share
 1.47 1.44 1.33 1.30 1.37
Free Cash Flow Per Share
 1.37 1.44 1.33 1.30 1.37
CapEx Per Share
 0.10 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 0.93 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 1.15 1.20 1.11 1.08 1.14
Capital Expenditure Coverage Ratio
 14.77 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 0.14 0.14 0.13 0.12 0.12
Operating Cash Flow to Sales Ratio
 0.43 0.45 0.44 0.46 0.51
Free Cash Flow Yield
6.60%7.63%7.68%9.11%11.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 78.83 29.59 32.07 239.84 -36.99
Price-to-Sales (P/S) Ratio
 6.11 5.90 5.75 5.10 4.59
Price-to-Book (P/B) Ratio
 1.91 1.62 1.48 1.18 0.94
Price-to-Free Cash Flow (P/FCF) Ratio
 15.15 13.11 13.02 10.98 9.09
Price-to-Operating Cash Flow Ratio
 14.13 13.11 13.02 10.98 9.09
Price-to-Earnings Growth (PEG) Ratio
 -1.18 1.60 0.04 -2.04 1.07
Price-to-Fair Value
 1.91 1.62 1.48 1.18 0.94
Enterprise Value Multiple
 21.35 15.43 15.58 18.30 24.76
Enterprise Value
 7.66B 7.05B 6.43B 5.70B 5.37B
EV to EBITDA
 21.35 15.43 15.58 18.30 24.76
EV to Sales
 8.91 9.10 9.14 8.81 8.60
EV to Free Cash Flow
 22.12 20.22 20.70 18.98 17.01
EV to Operating Cash Flow
 20.62 20.22 20.70 18.98 17.01
Tangible Book Value Per Share
 10.58 11.43 11.62 11.99 13.06
Shareholders’ Equity Per Share
 10.90 11.69 11.74 12.12 13.23
Tax and Other Ratios
Effective Tax Rate
 >-0.01 0.01 <0.01 0.13 -0.02
Revenue Per Share
 3.41 3.21 3.01 2.80 2.71
Net Income Per Share
 0.26 0.64 0.54 0.06 -0.34
Tax Burden
 1.04 0.99 0.99 0.87 1.02
Interest Burden
 0.42 0.58 0.53 0.12 -2.62
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.07 0.07 0.07 0.07 0.06
Stock-Based Compensation to Revenue
 0.02 0.01 0.01 0.01 0.01
Income Quality
 5.69 2.24 2.45 21.85 -4.07
Currency in USD